Neutrophil elastase up-regulates interleukin-8 via toll-like receptor 4  by Devaney, James M et al.
Neutrophil elastase up-regulates interleukin-8 via toll-like receptor 4
James M. Devaney, Catherine M. Greene, Cli¡ord C. Taggart, Toma¤s P. Carroll,
Shane J. O’Neill, Noel G. McElvaney
Respiratory Research, Department of Medicine, RCSI Education and Research Centre, Smur¢t Building, Beaumont Hospital, Dublin 9, Ireland
Received 25 February 2003; revised 14 April 2003; accepted 14 April 2003
First published online 12 May 2003
Edited by Beat Imhof
Abstract Cystic ¢brosis is characterised in the lungs by high
levels of neutrophil elastase (NE). NE induces interleukin-8 (IL-
8) expression via an IL-1 receptor-associated kinase signalling
pathway. Here, we show that these events involve the cell sur-
face membrane bound toll-like receptor 4 (TLR4). We demon-
strate that human embryonic kidney (HEK)293 cells transfected
with a TLR4 cDNA (HEK-TLR4) express TLR4 mRNA and
protein and induce IL-8 promoter activity in response to NE.
Treatment of both HEK-TLR4 and human bronchial epithelial
cells with NE decreases TLR4 protein expression. Furthermore,
a TLR4 neutralising antibody abrogates NE-induced IL-8 pro-
duction, and induces tolerance to a secondary lipopolysaccharide
stimulus. These data implicate TLR4 in NE induced IL-8 ex-
pression in bronchial epithelium.
1 2003 Federation of European Biochemical Societies. Pub-
lished by Elsevier Science B.V. All rights reserved.
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1. Introduction
Cystic ¢brosis (CF) is an autosomal recessive inherited dis-
order, characterised by mutations in the gene encoding the CF
transmembrane conductance regulator protein ^ CFTR [1,2].
It is one of the most common lethal hereditary disorders
among caucasians of European descent [3]. The clinical char-
acteristics include bacterial colonisation in the lung, produc-
tion of thick mucous and recurrent infection, leading to mor-
bidity and mortality in 95% of patients [4]. In£ammation in
the CF lung is dominated by neutrophils and their products,
including neutrophil elastase (NE), an omnivorous protease
capable of degrading components of the lung matrix. The
interaction between neutrophils and lung cytokines largely
determines the nature and persistence of the in£ammatory
response in CF [5].
We have previously elucidated the intracellular signalling
pathways involved in NE induction of interleukin-8 (IL-8)
gene expression in human bronchial epithelial (HBE) cells
[6]. These data demonstrate that HBEs express the IL-8
gene and produce IL-8 protein, and that these responses are
up-regulated by NE. We further demonstrated the involve-
ment of the signal transducing molecules IL-1 receptor-asso-
ciated kinase (IRAK), MyD88 and TRAF6, in NE-induced
NFUB activation and IL-8 expression. This pathway has been
reported to transduce signals for the IL-1 receptor (IL-1R)/
toll-like receptor (TLR) superfamily, a recently de¢ned and
expanding group of receptors that participate in immune
and in£ammatory responses [7]. TLRs compose a large family
with 10 members (TLR1^10) [8^12], which play an important
role in the recognition of microbial components, with subse-
quent activation of innate immunity leading to development
of adaptive immune responses [13]. The prototypical TLR is
TLR4, which is the recognised receptor for lipopolysaccharide
(LPS) [14,15].
Neutrophil accumulation on the airway epithelial surface is
an essential component of normal host defence against infec-
tion. When exaggerated it can cause progressive damage to
the bronchial epithelium. In CF, this damage is mediated sig-
ni¢cantly by NE [16,17]. We have previously shown that IL-8,
a potent chemoattractant and activator of neutrophils, is re-
leased by bronchial epithelial cells in response to NE [6]. In
this study, we show that this IL-8 up-regulation by NE occurs
in part through the cell surface membrane bound TLR4.
2. Materials and methods
2.1. Cell culture
The human embryonic kidney cell line, HEK293, (ECACC-
85120602) was obtained from the European Collection of Cell Cul-
tures. Cells were cultured at 37‡C in Eagle’s minimal essential medium
(EMEM, Biowhittaker) supplemented with 10% foetal bovine serum
(FBS), 1% L-glutamine, 1% penicillin/streptomycin, 1% NEAA (Gib-
co-BRL). 16HBE14o3 (HBE) cells, an SV-40-transformed HBE cell
line [18] was obtained as a gift from D. Gruenert (University of
Vermont). The cells were cultured as above without 1% NEAA.
2.2. Transfection and reporter gene studies
Construction of the IL-8 luciferase reporter plasmid was previously
described [6]. HEK cells were seeded at 5U105 on six-well plates 24 h
before transfection. Transfections were performed with TransFast
(Promega) using 200 ng of IL-8 luciferase plasmid and 200 ng of
either pcDNA3 or a TLR4 expression plasmid (a gift from Marta
Muzio [19]). All cells were transfected with a L-galactosidase control
plasmid for normalising transfection e⁄ciencies. Cells were lysed with
reporter lysis bu¡er (Promega), protein concentrations were deter-
mined [20], and IL-8 reporter gene activity was quanti¢ed by lumin-
ometry (Wallac Victor2, 1420 multilabel counter). Reporter gene ex-
pression is expressed as light units (L.U.)/Wg total protein.
2.3. RNA isolation and analysis
Total RNA was isolated from HEK cells using TRI reagent (Sig-
ma). 1 Wg total RNA was reverse transcribed into cDNA with an
oligo(dT)15 primer, using ¢rst strand cDNA synthesis kit (Roche).
TLR4- or glyceraldehyde-3-phosphate dehydrogenase (GAPDH)-spe-
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ci¢c polymerase chain reactions (PCRs) were performed followed by
resolution of the 481-bp TLR4 products and the 211-bp GAPDH
products on a 1.5% TBE agarose gel containing 0.5 Wg/ml ethidium
bromide (Sigma).
2.4. Western blotting
HBE or HEK293 cells (1U106/ml) were exposed to NE (50 nM) for
20 min and total protein extracts were prepared as described [20].
Protein extracts (10 Wg) were electrophoresed on a 10% sodium do-
decyl sulphate (SDS)^polyacrylamide gel and transferred to a nitro-
cellulose membrane. Non-speci¢c binding was blocked and immuno-
reactive proteins were detected by speci¢c antibodies (TLR4 from
Serotec; IRAK from Transduction Laboratories), alkaline phospha-
tase-conjugated anti-mouse IgG (Promega) and CDP-Star chemilumi-
nescent substrate solution (Tropix).
2.5. Laser scanning cytometry (LSC)
To quantify TLR4 cell surface expression on HBE cells, 2U104 cells
were seeded in eight-well chamber slides in serum-free medium for 24 h
prior to exposure to NE (50 nM, 20 min). Cells were Fc-blocked with
1 Wg/ml goat IgG then labelled with mouse IgG2A anti-human TLR4
and an £uorescein isothiocyanate (FITC)-labelled anti-mouse F(ab)2
(Dako). Isotype control samples were also prepared. Cells were coun-
terstained with propidium iodide (Molecular Probes) and LSC (Com-
pucyte, Cambridge, MA, USA) was used to quantify cell surface
TLR4 expression. FITC and PI cellular £uorescence of at least
5U103 cells was measured by separate photomultipliers at 530R 20
nm and s 610 nm, respectively. Individual TLR4-expressing cells
were identi¢ed and quanti¢ed using CompuCyte software on the basis
of integrated green £uorescence.
2.6. IL-8 protein production
HBE cells were seeded at 1U105 on 24-well plates 24 h before
stimulation. Cells were left untreated or stimulated with 50 nM NE
for 4 h, or 20 Wg/ml LPS (Sigma) for 20 h. Prior to NE treatment,
some cells were incubated for 1 h with an isotype control antibody
(RpD Systems Inc., Minneapolis, MN, USA) or a mouse anti-TLR4
neutralising antibody (Serotec) and IL-8 protein concentrations in the
cell supernatants were determined by enzyme-linked immunosorbent
assays (ELISA) (RpD Systems Inc., Minneapolis, MN, USA). Values
are expressed as pg/ml IL-8.
2.7. Statistical analyses
Data were analysed with GraphPad Prism 2.0 software package
(GraphPad Software, San Diego, CA, USA). Results are expressed
as meansRS.E.M. and were compared by Mann^Whitney test. Di¡er-
ences were considered signi¢cant when the P value was 9 0.05.
3. Results
3.1. HEK-TLR4 cells express TLR4 mRNA and protein and
IL-8 is up-regulated following stimulation with NE
HEK293 cells transiently transfected with a human TLR4
cDNA (HEK-TLR4) expressed both TLR4 mRNA and
TLR4 protein (Fig. 1A and B). HEK-TLR4 cells cotrans-
fected with an IL-8 luciferase reporter gene expressed higher
basal levels of luciferase compared to mock-transfected cells.
Upon exposure to NE, HEK-TLR4 cells showed a two-fold
increase in luciferase expression compared to HEK-TLR4
cells alone (P6 0.0001). This is compared to no increase be-
tween HEK cells treated with NE or left untreated (Fig. 2).
HEK-TLR4 cells exposed to NE also showed decreased TLR4
by Western blot analysis (Fig. 3A), with simultaneous degra-
dation of IRAK (Fig. 3B).
3.2. NE decreases TLR4 surface expression on HBE cells
In subsequent experiments using the human cell line
16HBE14o3 (HBE), NE was shown by LSC to decrease cell
surface expression of TLR4 (Fig. 4A), with simultaneous
IRAK degradation shown by Western blotting (Fig. 4, inset).
HBE cells exposed to NE also showed decreased TLR4 by
Western blot analysis (Fig. 4B).
3.3. A TLR4 neutralising antibody inhibits NE-induced IL-8
production from HBE cells
HBE cells were next analysed for IL-8 protein production
(Fig. 5). Cells treated with NE expressed two-fold higher lev-
els of IL-8 than control cells (129R 12 vs. 70R 9 pg/ml IL-8).
Pre-treatment with a TLR4 neutralising antibody prior to ex-
posure to NE signi¢cantly inhibited NE-induced IL-8 produc-
tion (78R 7 pg/ml IL-8) (P=0.0178). An isotype antibody had
no e¡ect (not shown).
Fig. 1. HEK293 cell line transfected with human TLR4 cDNA expresses TLR4 mRNA and TLR4 protein. HEK293 cells (5U105/ml) were
transfected with 200 ng of pcDNA3 or pcDNA-TLR4. A: Total RNA was extracted, 1 ug was reverse transcribed into cDNA and used in
PCRs. Lane 1, PCR positive control (pcDNA3-TLR4); lane 2, HEK-TLR4; lane 3, HEK-pcDNA3 (n=3). B: Total protein was extracted and
10 ug was used in Western blots. Lane 1, HEK293; lane 2, HEK-TLR4 (n=3).
Fig. 2. NE up-regulates IL-8 via TLR4. HEK293 and HEK-TLR4
cells (5U105/ml) were left untreated or stimulated with NE (50 nM,
4 h). Levels of luciferase in cell extracts were measured and values
are expressed as L.U./Wg protein. (*P6 0.0001). Assays were per-
formed in duplicate (n=3).
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3.4. NE induces tolerance to LPS in HBE cells
We next examined whether NE could induce tolerance to a
secondary LPS stimulus in HBE cells (Fig. 6). Both NE and
LPS increased IL-8 protein production from HBE cells at 4
and 20 h, respectively (120R 10, 216R 10 and 1364R 20 pg/ml
IL-8 for control, NE and LPS, respectively) (*P=0.05). Pre-
treatment for 4 h with NE, followed by removal of the NE
and stimulation with LPS for a further 20 h blunted the LPS
response (440R 30 pg/ml IL-8) (#P=0.05), indicating that NE
can induce LPS tolerance.
4. Discussion
The intracellular mechanism by which NE up-regulates IL-8
in bronchial epithelial cells is mediated in part by MyD88/
IRAK/TRAF6 resulting in activation of NFUB [6]. These sig-
nal transducers have been implicated in pathways activated by
the TLR/IL-1R family of proteins [7,8]. In this study, we show
that NE acts to up-regulate IL-8 through TLR4, via the
IRAK pathway.
Neutrophil-dominated in£ammation is a major component
of CF airway disease. Much of the lung damage mediated by
neutrophils in CF is through the action of NE [16,21]. At-
tempts to inhibit NE activity in vivo have been hampered by
the enormous NE burden [22].
IL-8 is an important proin£ammatory chemokine in CF.
Clinical studies have demonstrated high levels of active IL-8
in the airways and sputum of CF patients at virtually all
stages of disease [5,23,24]. In this regard, identi¢cation of
the signalling pathways and cellular events involved in NE-
induced in£ammation is of critical importance in that inhibi-
tion at these levels may diminish the in£ammatory response
more e¡ectively than standard anti-protease therapies.
We have previously elucidated part of the intracellular sig-
nalling pathways involved in NE induction of IL-8 gene ex-
pression in BECs [6] by demonstrating the involvement of the
signal transducers IRAK, MyD88, and TRAF-6. Here we
show that TLR4 is involved in NE-induced IL-8 protein pro-
duction in HBE cells and HEK cells expressing a TLR4
cDNA.
The HEK-TLR4 cells showed increased basal level of IL-8
luciferase activity compared to parental cells. Transfection of
the cDNA for the functional TLR4 receptor led to expression
of TLR4 mRNA and protein (Fig. 1), this overexpression can
lead to activation of downstream e¡ectors. It has previously
been shown that this e¡ect can be inhibited by the LPS antag-
onist E5531 [25]. There was no e¡ect on IRAK-1 in HEK-
Fig. 3. NE decreases TLR4 expression. HEK-TLR4 cells (5U105/ml) were left untreated or stimulated with NE (50 nM, 20 min). Total protein
was extracted and 10 ug was used in Western blots to detect TLR4 (A) or IRAK (B). Lane 1, HEK-TLR4; lane 2, HEK-TLR4 plus 50 nM
NE/20 min (n=5).
Fig. 4. NE decreases TLR4 expression in 16HBE14o3 cells. HBE
cells (2U104/ml) were left untreated or stimulated with NE (50 nM,
20 min). A: Black clear, isotype control; black solid, untreated
cells ; grey, 50 nM NE/20 min. Inset: IRAK Western blot: lane 1,
untreated cells ; lane 2, 50 nM NE/20 min (n=5). B: HBE cells
(5U105/ml) were left untreated or stimulated with NE (50 nM, 20
min). Total protein was extracted and 10 ug was used in Western
blots to detect TLR4. Lane 1, untreated; lane 2, 50 nM NE/20 min
(n=3).
Fig. 5. TLR4 neutralising antibody blocks NE-induced up-regula-
tion of IL-8. HBE cells (1U106/ml) were left untreated or were
stimulated with NE (50 nM, 4 h). Addition of TLR4 antibody (Ab)
to HBE cells attenuated the e¡ects of NE exposure (*P=0.0178).
Assays were performed in duplicate (n=3).
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TLR4 cells. We found that the cells responded normally to
NE stimulation by degrading IRAK (Fig. 3B). However, it is
possible that IRAK-2 or IRAK-4 may be responsible for
transducing the ‘basal’ signal.
LPS is ubiquitous in the CF lung and TLR4 is recognised
as the receptor responsible for transducing the LPS signal.
This response is enhanced by the presence of MD-2 [26]. In
this study we show that NE can transduce a signal through
TLR4 in the absence of MD-2, since HEK293 cells have been
shown not to express MD-2. The mechanism by which NE
initiates in£ammation via TLR4 is associated with decreased
TLR4 surface expression. This may be similar to the mecha-
nism of LPS-induced TLR4 internalisation [27] or alterna-
tively could be a result of cleavage by NE.
The observed NE-induced decrease in TLR4 expression on
HBE cells (Fig. 4) suggested that NE may be inducing toler-
ance in HBE cells. This is the phenomenon by which activated
cells become recalcitrant to secondary stimulation and has
been studied in detail for LPS and other TLR ligands. Using
NE as a primary stimulus and LPS as a secondary stimulus,
we found that the NE could blunt the LPS-induced IL-8 re-
sponse compared to stimulation with LPS alone. This pro-
vides further evidence that NE is exerting its e¡ects via TLR4.
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